Skip to main navigation Skip to search Skip to main content

Analysis of patients (pts) with unresectable hepatocellular carcinoma (uHCC) and Child–Pugh (CP)-B liver function treated with regorafenib in routine clinical practice in the observational REFINE study.

Christopher J.D. Wallis, Raj Satkunasivam, David Dan Nguyen, Khatereh J.D. Aminoltejari, Amanda Elizabeth Hird, Soumyajit Roy, Scott C. Morgan, Shawn Malone, Bobby Shayegan, Rodney H. Breau

Research output: Contribution to journal › Article › peer-review

2   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Analysis of patients (pts) with unresectable hepatocellular carcinoma (uHCC) and Child–Pugh (CP)-B liver function treated with regorafenib in routine clinical practice in the observational REFINE study.'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science